Advertisement

Pathologie pp 993-1081 | Cite as

Thymus

  • Philipp Ströbel
  • Alexander Marx
Chapter

Zusammenfassung

In diesem Kapitel wird mit Ausnahme der primär diesem Organ zugeordneten malignen Lymphome die gesamte Thymus-Pathologie umfassend und pathogenetisch dargestellt. Nach der Einführung in die Entwicklung und Funktion des Organs und dessen Histophysiologie werden die Fehlbildungen und Immundefekterkrankungen, sowie die Entwicklung der altersabhängigen und akzidentellen Thymusinvolution und Zustände einer Thymushyperplasie besprochen. Es folgt eine Darstellung der verschiedenen Formen der Myasthenia gravis und der charakteristischen Thymusbefunde. Dann werden auf dem Boden der neuen WHO Klassifikation sämtliche epithelialen Thymustumoren, ihre pathologische Bewertung und Prognose und schließlich die seltenen mesenchymalen Tumoren des Thymus und seiner Umgebung und die mediastinalen Keimzelltumoren und Teratome diskutiert. Der komplexe Inhalt wird durch übersichtliche Tabellen und viele Abbildungen ergänzt, sodass auch der nur selten mit dieser speziellen Pathologie konfrontierte Pathologe einen klaren Weg in der Diagnostik sieht.

Literatur

  1. 1.
    Adam P, Hakroush S, Hofmann I, Reidenbach S, Marx A, Ströbel P (2014) Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Virchows Arch 465:313–320PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Agatsuma T, Koizumi T, Kubo K, Saito G, Kondo R, Yoshida K, Ito K, Endo M, Shimojo H (2011) Mediastinal growing teratoma syndrome successfully treated by multiple modality therapies. Intern Med 50:607–610PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso PL, Ruffini E, Travis W, Jones DR, Zhan Y, Lucchi M, Rimner A (2015) Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg 149:95–100 (101e101–102)PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Ahn C, Harvey JC (1990) Mediastinal hibernoma, a rare tumor. Ann Thorac Surg 50:828–830PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Akiyama T, Shimo Y, Yanai H, Qin J, Ohshima D, Maruyama Y, Asaumi Y, Kitazawa J, Takayanagi H, Penninger JM, Matsumoto M, Nitta T, Takahama Y, Inoue J (2008) The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. Immunity 29:423–437PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL (2009) Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol 33:645–658PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Anderson T, Zhang L, Hameed M, Rusch V, Travis WD, Antonescu CR (2015) Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions. Am J Surg Pathol 39:132–139PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Appay V, Sauce D, Prelog M (2010) The role of the thymus in immunosenescence: lessons from the study of thymectomized individuals. Aging (albany Ny) 2:78–81CrossRefGoogle Scholar
  9. 9.
    Arliss J, Scholes J, Dickson PR, Messina JJ (1988) Massive thymic hyperplasia in an adolescent. Ann Thorac Surg 45:220–222PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Atkinson JB, Mahour GH, Isaacs H Jr, Ortega JA (1984) Hemangiopericytoma in infants and children. A report of six patients. Am J Surg 148:372–374PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Barik A, Lu Y, Sathyamurthy A, Bowman A, Shen C, Li L, Xiong WC, Mei L (2014) LRP4 is critical for neuromuscular junction maintenance. J Neurosci 34:13892–13905PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Berrih-Aknin S, Ragheb S, Le Panse R, Lisak RP (2013) Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmun Rev 12:885–893PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Berrih-Aknin S, Ruhlmann N, Bismuth J, Cizeron-Clairac G, Zelman E, Shachar I, Dartevelle P, de Rosbo NK, Le Panse R (2009) CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. Ann Neurol 66:521–531PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Bhora FY, Chen DJ, Detterbeck FC, Asamura H, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Kondo K, Lucchi M, Marino M, Marom EM, Nicholson AG, Okumura M, Ruffini E, Van Schil P, Staging, Prognostic Factors C, Advisory B (2014) The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 9(Suppl 2):88–96CrossRefGoogle Scholar
  16. 16.
    Billard MJ, Gruver AL, Sempowski GD (2011) Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS ONE 6:e17940PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Bockman DE (1968) Myoid cells in adult human thymus. Nature 218:286–287PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Boder E, Sedgwick RP (1958) Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. Pediatrics 21:526–554PubMedPubMedCentralGoogle Scholar
  19. 19.
    Boehm T, Bleul CC (2007) The evolutionary history of lymphoid organs. Nat Immunol 8:131–135PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Boersma W, Betel I, van der Westen G (1979) Thymic regeneration after dexamethasone treatment as a model for subpopulation development. Eur J Immunol 9:45–52PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Bokemeyer C, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Einhorn L, Nichols CR, Hartmann JT (2001) Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome. Cancer 91:1394–1401PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT (2002) Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol 20:1864–1873PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Boland JM, Colby TV, Folpe AL (2012) Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features. Am J Surg Pathol 36:1395–1403PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Bonnette P, Jouan J, Colchen A, Epardeau B, Grapin D, Grapin JP (2000) Myxoid liposarcoma of the mediastinum. Rev Mal Respir 17:109–111PubMedPubMedCentralGoogle Scholar
  25. 25.
    Bornemann A, Kirchner T (1996) An immuno-electron-microscopic study of human thymic B cells. Cell Tissue Res 284:481–487PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Bosl GJ, Dmitrovsky E, Reuter VE, Samaniego F, Rodriguez E, Geller NL, Chaganti RS (1989) Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors. J Natl Cancer Inst 81:1874–1878PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O’Leary LA, Wong LY, Elixson EM, Mahle WT, Campbell RM (2003) A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112(Pt 1):101–107PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Bouchikh M, Arame A, Riquet M, Le Pimpec-Barthes F (2013) Cardiac failure due to a giant desmoid tumour of the posterior mediastinum. Eur J Cardiothorac Surg 44:1137–1139PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Bowden DH, Danis PG, Sommers SC (1963) Ataxia-telangiectasia. a case with lesions of ovaries and adenohypophysis. J Neuropathol Exp Neurol 22:549–554PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Brambilla E, Beasley MB, Austin JHM, Capolezzi VL, Chiriac LR, Devesa SS, Frank GA, Gazdar A, Ishikawa Y, Jen J, Jett J, Marchevsky AM, Nicholson S, Pelosi G, Powell CA, Rami-Porta R, Scagliotti G, Thunnissen E, Travis W, Van Schil P, Yang P (2015) WHO classification of tumours of the lung, pleura, thymus and heart. WHO Classification of Tumours. IARC, Lyon, S 63–85Google Scholar
  31. 31.
    Brown JG, Familiari U, Papotti M, Rosai J (2009) Thymic basaloid carcinoma: a clinicopathologic study of 12 cases, with a general discussion of basaloid carcinoma and its relationship with adenoid cystic carcinoma. Am J Surg Pathol 33:1113–1124PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N (2001) Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol 50:64–72PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Cai JN, Shi M, Wang J (2011) Perivascular epithelioid cell tumor, not otherwise specified: a clinicopathologic and immunohistochemical analysis of 31 cases. Zhonghua Bing Li Xue Za Zhi 40:240–245PubMedPubMedCentralGoogle Scholar
  34. 34.
    Chaganti RS, Rodriguez E, Mathew S (1994) Origin of adult male mediastinal germ-cell tumours. Lancet 343:1130–1132PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Chalabreysse L, Etienne-Mastroianni B, Adeleine P, Cordier JF, Greenland T, Thivolet-Bejui F (2004) Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases. Histopathology 44:367–374PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F (2002) Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 26:1605–1611PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Chariot P, Monnet I, Gaulard P, Abd-Alsamad I, Ruffie P, De Cremoux H (1993) Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed. Hum Pathol 24:111–112PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Chen CH, Lin RL, Liu HC, Chen CH, Hung TT, Huang WC (2008) Inflammatory myofibroblastic tumor mimicking anterior mediastinal malignancy. Ann Thorac Surg 86:1362–1364PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Chen G, Marx A, Chen WH, Yong J, Puppe B, Stroebel P, Mueller-Hermelink HK (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Cancer 95:420–429PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Chen TS, Montgomery EA (2008) Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders? J Clin Pathol 61:1093–1097PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Chertoff J, Barth RA, Dickerman JD (1991) Rebound thymic hyperplasia five years after chemotherapy for Wilms’ tumor. Pediatr Radiol 21:596–597PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Chetty R, Batitang S, Govender D (1997) Large cell neuroendocrine carcinoma of the thymus. Histopathology 31:274–276PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Cheuk W, Chan JK (2010) IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17:303–332PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Chinn IK, Milner JD, Scheinberg P, Douek DC, Markert ML (2013) Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)+ and FoxP3- T cells in complete DiGeorge anomaly. Clin Exp Immunol 173:140–149PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Christopoulos P, Dopfer EP, Malkovsky M, Esser PR, Schaefer HE, Marx A, Kock S, Rupp N, Lorenz MR, Schwarz K, Harder J, Martin SF, Werner M, Bogdan C, Schamel WW, Fisch P (2015) A novel thymoma-associated immunodeficiency with increased naive T cells and reduced CD247 expression. J Immunol 194:3045–3053PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Chuang WY, Ströbel P, Bohlender-Willke AL, Rieckmann P, Nix W, Schalke B, Gold R, Opitz A, Klinker E, Inoue M, Müller-Hermelink HK, Saruhan-Direskeneli G, Bugert P, Willcox N, Marx A (2014) Late-onset myasthenia gravis – CTLA4(low) genotype association and low-for-age thymic output of naive T cells. J Autoimmun 52:122–129PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Chuang WY, Ströbel P, Gold R, Nix W, Schalke B, Kiefer R, Opitz A, Klinker E, Müller-Hermelink HK, Marx A (2005) A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol 58:644–648PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Chun HH, Gatti RA (2004) Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 3:1187–1196CrossRefGoogle Scholar
  50. 50.
    Coffin CM, Watterson J, Priest JR, Dehner LP (1995) Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 19:859–872PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Cohen AJ, Sbaschnig RJ, Hochholzer L, Lough FC, Albus RA (1987) Mediastinal hemangiomas. Ann Thorac Surg 43:656–659PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Cohn M, Giuffra L, Demos N (1983) Temporary vocal cord paralysis in fibrosing mediastinitis. J Med Soc N J 80:841–843PubMedPubMedCentralGoogle Scholar
  53. 53.
    Cooper MD, Chae HP, Lowman JT, Krivit W, Good RA (1968) Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 44:499–513PubMedPubMedCentralCrossRefGoogle Scholar
  54. 54.
    Cordiglieri C, Marolda R, Franzi S, Cappelletti C, Giardina C, Motta T, Baggi F, Bernasconi P, Mantegazza R, Cavalcante P (2014) Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity. J Autoimmun 52:74–89PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Costa-Carvalho BT, de Moraes-Pinto MI, de Almeida LC, de Seixas Alves MT, Maia RP, de Souza RL, Barreto M, Lourenco L, Vicente AM, Coutinho A, Carneiro-Sampaio M (2008) A remarkable depletion of both naive CD4+ and CD8+ with high proportion of memory T cells in an IPEX infant with a FOXP3 mutation in the forkhead domain. Scand J Immunol 68:85–91PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Crona J, Bjorklund P, Welin S, Kozlovacki G, Oberg K, Granberg D (2013) Treatment, prognostic markers and survival in thymic neuroendocrine tumours. a study from a single tertiary referral centre. Lung Cancer 79:289–293PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Crotty TB, Colby TV, Gay PC, Pisani RJ (1992) Desmoplastic malignant mesothelioma masquerading as sclerosing mediastinitis: a diagnostic dilemma. Hum Pathol 23:79–82PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Cufi P, Dragin N, Ruhlmann N, Weiss JM, Fadel E, Serraf A, Berrih-Aknin S, Le Panse R (2014) Central role of interferon-beta in thymic events leading to myasthenia gravis. J Autoimmun 52:44–52PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Dalla Costa M, Mangano FA, Betterle C (2014) Thymic hyperplasia in patients with Graves’ disease. J Endocrinol Invest 37:1175–1179PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Damjanov I, Niejadlik DC, Rabuffo JV, Donadio JA (1980) Cribriform and sclerosing seminoma devoid of lymphoid infiltrates. Arch Pathol Lab Med 104:527–530PubMedPubMedCentralGoogle Scholar
  61. 61.
    de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van de Geijn GJ, Boer M, Hersmus R, Saunders PT, Anderson RA, Oosterhuis JW, Looijenga LH (2008) Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications. J Pathol 215:21–30PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    de Jong WK, Blaauwgeers JL, Schaapveld M, Timens W, Klinkenberg TJ, Groen HJ (2008) Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy. Eur J Cancer 44:123–130PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    de Montpreville VT, Macchiarini P, Dulmet E (1996) Thymic neuroendocrine carcinoma (carcinoid): a clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111:134–141PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    de Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S (2002) Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome. Ann Thorac Surg 73:675–681PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Demir HA, Yalcin B, Buyukpamukcu N, Kale G, Varan A, Akyuz C, Kutluk T, Buyukpamukcu M (2010) Thoracic neuroblastic tumors in childhood. Pediatr Blood Cancer 54:885–889PubMedPubMedCentralGoogle Scholar
  66. 66.
    Detterbeck FC (2006) Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 81:2328–2334PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Dham A, Truskinovsky AM, Dudek AZ (2008) Thymic carcinoid responds to neoadjuvant therapy with sunitinib and octreotide: a case report. J Thorac Oncol 3:94–97PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Di Tommaso L, Kuhn E, Kurrer M, Zettl A, Marx A, Müller-Hermelink HK, Roncalli M, Rosai J (2007) Thymic tumor with adenoid cystic carcinomalike features: a clinicopathologic study of 4 cases. Am J Surg Pathol 31:1161–1167PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Dorfman DM, Shahsafaei A, Chan JK (1997) Thymic carcinomas, but not thymomas and carcinomas of other sites, show CD5 immunoreactivity. Am J Surg Pathol 21:936–940PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690–695PubMedPubMedCentralCrossRefGoogle Scholar
  71. 71.
    Doyle LA, Fletcher CD (2013) Predicting behavior of solitary fibrous tumor: are we getting closer to more accurate risk assessment? Ann Surg Oncol 20:4055–4056PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27:390–395PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Ducatman BS, Scheithauer BW (1984) Malignant peripheral nerve sheath tumors with divergent differentiation. Cancer 54:1049–1057PubMedPubMedCentralCrossRefGoogle Scholar
  74. 74.
    Dulmet EM, Macchiarini P, Suc B, Verley JM (1993) Germ cell tumors of the mediastinum. A 30-year experience. Cancer 72:1894–1901PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Dumont P, de Muret A, Skrobala D, Robin P, Toumieux B (1997) Calcifying fibrous pseudotumor of the mediastinum. Ann Thorac Surg 63:543–544PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Dunn PJ (1984) Pancreatic endocrine tissue in benign mediastinal teratoma. J Clin Pathol 37:1105–1109PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Economopoulos GC, Lewis JW Jr, Lee MW, Silverman NA (1990) Carcinoid tumors of the thymus. Ann Thorac Surg 50:58–61PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Elmas C, Erdogan D, Take G, Ozogul C, Nacar A, Koksal M (2008) Ultrastructure of the thymus in diabetes mellitus and starvation. Adv Ther 25:67–76PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    England DM, Hochholzer L, McCarthy MJ (1989) Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 13:640–658PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, Healey JH, Antonescu CR (2011) A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer 50:644–653PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Ertugrul T, Dindar A, Elmaci TT, Onursal E, Kilicaslan I (2001) An intrapericardial teratoma with endocrine function. J Cardiovasc Surg (torino) 42:781–783Google Scholar
  82. 82.
    Esme H, Eren S, Sezer M, Solak O (2011) Primary mediastinal cysts: clinical evaluation and surgical results of 32 cases. Tex Heart Inst J 38:371–374PubMedPubMedCentralGoogle Scholar
  83. 83.
    Ferri C, Colaci M, Battolla L, Giuggioli D, Sebastiani M (2006) Thymus alterations and systemic sclerosis. Rheumatology (Oxford) 45:72–75CrossRefGoogle Scholar
  84. 84.
    Filosso PL, Yao X, Ahmad U, Zhan Y, Huang J, Ruffini E, Travis W, Lucchi M, Rimner A, Antonicelli A, Guerrera F, Detterbeck F, European Society of Thoracic Surgeons Thymic Group Steering C (2015) Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases. J Thorac Cardiovasc Surg 149:103–109e102PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M (2013) Gene therapy of primary T cell immunodeficiencies. Gene 525:170–173PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Flannery MT, Espino M, Altus P, Messina J, Wallach PM (1994) Hodgkin’s disease masquerading as sclerosing mediastinitis. South Med J 87:921–923PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Fletcher CD, Davies SE, McKee PH (1987) Cellular schwannoma: a distinct pseudosarcomatous entity. Histopathology 11:21–35PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Flieder DB, Moran CA, Suster S (1997) Primary alveolar soft-part sarcoma of the mediastinum: a clinicopathological and immunohistochemical study of two cases. Histopathology 31:469–473PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Forster C, Ostertag H, Macchiarini P (2002) Infiltrative mediastinal hemangioma. Eur J Cardiothorac Surg 21:541CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Fraisse T, Labauge P, Camu W, Arlaud P, de Wazieres B (2007) Myasthenia gravis in the elderly: diagnosis, comorbidity and course: 45 cases. Press Med 36:9–14CrossRefGoogle Scholar
  92. 92.
    Fujinaga K, Sakamoto S, Sawada Y, Tanaka J, Mizumoto T (2012) Recurrent mediastinal desmoid tumor treated by surgical resection; report of a case. Kyobu Geka 65:252–254PubMedPubMedCentralGoogle Scholar
  93. 93.
    Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bjorkholm M, Landgren O, Giaccone G (2011) A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 128:2688–2694CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Gallivan MV, Chun B, Rowden G, Lack EE (1980) Intrathoracic paravertebral malignant paraganglioma. Arch Pathol Lab Med 104:46–51PubMedPubMedCentralGoogle Scholar
  95. 95.
    Garnick MB, Griffin JD (1983) Idiopathic thrombocytopenia in association with extragonadal germ cell cancer. Ann Intern Med 98:926–927PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Gartner LA, Voorhess ML (1993) Adrenocorticotropic hormone – producing thymic carcinoid in a teenager. Cancer 71:106–111PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sanchez-Perez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R, Group EW (2014) Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5 – a population-based study. Lancet Oncol 15:35–47PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Gaude GS, Patil P, Malur PR, Kangale R, Dhorigol V, Anurshetru S, Karanji J (2013) Primary mediastinal choriocarcinoma. South asian J Cancer 2:79PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Gaur P, Leary C, Yao JC (2010) Thymic neuroendocrine tumors: a SEER database analysis of 160 patients. Ann Surg 251:1117–1121PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F (2001) Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91:1905–1913CrossRefPubMedPubMedCentralGoogle Scholar
  101. 101.
    Gillard GO, Dooley J, Erickson M, Peltonen L, Farr AG (2007) Aire-dependent alterations in medullary thymic epithelium indicate a role for Aire in thymic epithelial differentiation. J Immunol 178:3007–3015CrossRefPubMedPubMedCentralGoogle Scholar
  102. 102.
    Gillis AJ, Stoop H, Biermann K, van Gurp RJ, Swartzman E, Cribbes S, Ferlinz A, Shannon M, Oosterhuis JW, Looijenga LH (2011) Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl 34:e160–e174CrossRefPubMedPubMedCentralGoogle Scholar
  103. 103.
    Girard N, Shen R, Guo T, Zakowski MF, Heguy A, Riely GJ, Huang J, Lau C, Lash AE, Ladanyi M, Viale A, Antonescu CR, Travis WD, Rusch VW, Kris MG, Pao W (2009) Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin Cancer Res 15:6790–6799PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Gobel U, Schneider DT, Teske C, Schonberger S, Calaminus G (2010) Brain metastases in children and adolescents with extracranial germ cell tumor - data of the MAHO/MAKEI-registry. Klin Padiatr 222:140–144CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A (2011) Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 6(Suppl 3):S1743–S1748CrossRefPubMedPubMedCentralGoogle Scholar
  106. 106.
    Goss PE, Schwertfeger L, Blackstein ME, Iscoe NA, Ginsberg RJ, Simpson WJ, Jones DP, Shepherd FA (1994) Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer 73:1971–1979PubMedPubMedCentralCrossRefGoogle Scholar
  107. 107.
    Gow KW, Kobrynski L, Abramowsky C, Lloyd D (2003) Massive benign thymic hyperplasia in a six-month-old girl: case report. Am Surg 69:717–719PubMedPubMedCentralGoogle Scholar
  108. 108.
    Gradolatto A, Nazzal D, Truffault F, Bismuth J, Fadel E, Foti M, Berrih-Aknin S (2014) Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha. J Autoimmun 52:53–63PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Gray DH, Seach N, Ueno T, Milton MK, Liston A, Lew AM, Goodnow CC, Boyd RL (2006) Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells. Blood 108:3777–3785PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Green AC, Marx A, Ströbel P, Mason M, Lim E, Jordan S, Ladas G, Dusmet M, Rice A, Nicholson AG (2015) Type A and AB thymomas: histological features associated with increased stage. Histopathology 66:884–891CrossRefPubMedPubMedCentralGoogle Scholar
  111. 111.
    Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Putz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A, Garchon HJ, Willcox N, Hammarstrom L, Seldin MF (2012) Risk for myasthenia gravis maps to a (151) Pro--〉Ala change in TNIP1 and to human leukocyte antigen-B*08. Ann Neurol 72:927–935PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Guerrera F, Rendina EA, Venuta F, Margaritora S, Ciccone AM, Novellis P, Novero D, Anile M, Bora G, Rena O, Casadio C, Mussi A, Evangelista A, Ruffini E, Lucchi M, Filosso PL (2015) Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients. Eur J Cardiothorac Surg 48:48–54CrossRefPubMedPubMedCentralGoogle Scholar
  113. 113.
    Gursoy S, Ozturk A, Ucvet A, Erbaycu AE (2009) Benign primary cystic lesions of mediastinum in adult: the clinical spectrum and surgical treatment. Arch Bronconeumol 45:371–375CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    Gururangan S, Bowman LC, Parham DM, Wilimas JA, Rao B, Pratt CB, Douglass EC (1993) Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide. Cancer 71:2653–2659CrossRefPubMedPubMedCentralGoogle Scholar
  115. 115.
    Gutmann L, Lemli L (1963) Ataxia-telangiectasia associated with hypogammaglobulinemia. Arch Neurol 8:318–327CrossRefPubMedPubMedCentralGoogle Scholar
  116. 116.
    Habel A, Herriot R, Kumararatne D, Allgrove J, Baker K, Baxendale H, Bu’Lock F, Firth H, Gennery A, Holland A, Illingworth C, Mercer N, Pannebakker M, Parry A, Roberts A, Tsai-Goodman B (2014) Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times. Eur J Pediatr 173:757–765PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Hahn HP, Fletcher CD (2007) Primary mediastinal liposarcoma: clinicopathologic analysis of 24 cases. Am J Surg Pathol 31:1868–1874CrossRefPubMedPubMedCentralGoogle Scholar
  118. 118.
    Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B (2005) Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine, Bd. 23, S 3232–3235Google Scholar
  119. 119.
    Hale LP, Buckley RH, Puck JM, Patel DD (2004) Abnormal development of thymic dendritic and epithelial cells in human X-linked severe combined immunodeficiency. Clin Immunol 110:63–70CrossRefPubMedPubMedCentralGoogle Scholar
  120. 120.
    Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS (2012) Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. J Clin Immunol 32:230–237CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    Hartel PH, Fanburg-Smith JC, Frazier AA, Galvin JR, Lichy JH, Shilo K, Franks TJ (2007) Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol 20:760–769CrossRefPubMedPubMedCentralGoogle Scholar
  122. 122.
    Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Fizazi K, Einhorn L, Kanz L, Bokemeyer C (2000) Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 92:54–61CrossRefPubMedPubMedCentralGoogle Scholar
  123. 123.
    Hawrylowicz CM, O’Garra A (2005) Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5:271–283CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Hazra R, Mackall C (2005) Thymic function in HIV infection. Curr Hiv/aids Rep 2:24–28CrossRefPubMedPubMedCentralGoogle Scholar
  125. 125.
    Heino M, Peterson P, Kudoh J, Nagamine K, Lagerstedt A, Ovod V, Ranki A, Rantala I, Nieminen M, Tuukkanen J, Scott HS, Antonarakis SE, Shimizu N, Krohn K (1999) Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 257:821–825CrossRefPubMedPubMedCentralGoogle Scholar
  126. 126.
    Heltzer ML, Choi JK, Ochs HD, Sullivan KE, Torgerson TR, Ernst LM (2007) A potential screening tool for IPEX syndrome. Pediatr Dev Pathol 10:98–105CrossRefPubMedPubMedCentralGoogle Scholar
  127. 127.
    Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol 69:418–422CrossRefPubMedPubMedCentralGoogle Scholar
  128. 128.
    Hirabayashi H, Fujii Y, Sakaguchi M, Tanaka H, Yoon HE, Komoto Y, Inoue M, Miyoshi S, Matsuda H (1997) p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma. Int J Cancer 73:639–644CrossRefPubMedPubMedCentralGoogle Scholar
  129. 129.
    Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R (2014) Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE 9:e89885PubMedPubMedCentralCrossRefGoogle Scholar
  130. 130.
    Hishida T, Yoshida J, Nishimura M, Ishii G, Nakao M, Nagai K (2009) Extraskeletal osteosarcoma arising in anterior mediastinum: brief report with a review of the literature. J Thorac Oncol 4:927–929CrossRefPubMedPubMedCentralGoogle Scholar
  131. 131.
    Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A (2000) Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 96:3872–3879PubMedPubMedCentralGoogle Scholar
  132. 132.
    Hollander GA, Wang B, Nichogiannopoulou A, Platenburg PP, van Ewijk W, Burakoff SJ, Gutierrez-Ramos JC, Terhorst C (1995) Developmental control point in induction of thymic cortex regulated by a subpopulation of prothymocytes. Nature 373:350–353CrossRefPubMedPubMedCentralGoogle Scholar
  133. 133.
    Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061CrossRefPubMedPubMedCentralGoogle Scholar
  134. 134.
    Hsueh C, Kuo TT, Tsang NM, Wu YC, Yang CP, Hung IJ (2006) Thymic lymphoepitheliomalike carcinoma in children: clinicopathologic features and molecular analysis. J Pediatr Hematol Oncol 28:785–790CrossRefPubMedPubMedCentralGoogle Scholar
  135. 135.
    Huang CS, Li WY, Lee PC, Kao KP, Chou TY, Wu MH, Hsu HS, Wu YC, Hsu WH, Huang BS (2014) Analysis of outcomes following surgical treatment of thymolipomatous myasthenia gravis: comparison with thymomatous and non-thymomatous myasthenia gravis. Interact Cardiovasc Thorac Surg 18:475–481CrossRefPubMedPubMedCentralGoogle Scholar
  136. 136.
    Huang H, Manton KG (2005) Newborn screening for severe combined immunodeficiency (SCID): a review. Front Biosci 10:1024–1039CrossRefPubMedPubMedCentralGoogle Scholar
  137. 137.
    Huang J, Rizk NP, Travis WD, Riely GJ, Park BJ, Bains MS, Dycoco J, Flores RM, Downey RJ, Rusch VW (2009) Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg 138:26–31PubMedPubMedCentralCrossRefGoogle Scholar
  138. 138.
    Hudacko R, Aviv H, Langenfeld J, Fyfe B (2009) Thymolipoma: clues to pathogenesis revealed by cytogenetics. Ann Diagn Pathol 13:185–188CrossRefPubMedPubMedCentralGoogle Scholar
  139. 139.
    Hussain R, Poindexter RW, Ottesen EA (1992) Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 148:2731–2737PubMedPubMedCentralGoogle Scholar
  140. 140.
    Iezzoni JC, Gaffey MJ, Weiss LM (1995) The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 103:308–315CrossRefPubMedPubMedCentralGoogle Scholar
  141. 141.
    Ikdahl T, Josefsen D, Jakobsen E, Delabie J, Fossa SD (2008) Concurrent mediastinal germ-cell tumour and haematological malignancy: case report and short review of literature. Acta Oncol 47:466–469CrossRefPubMedPubMedCentralGoogle Scholar
  142. 142.
    Ikehara S (2011) Thymus transplantation for treatment of cancer: lessons from murine models. Expert Rev Clin Immunol 7:205–211CrossRefPubMedPubMedCentralGoogle Scholar
  143. 143.
    Imai K, Saito H, Minamiya Y, Hashimoto M, Kimura Y, Ogawa J (2008) Malignant fibrous histiocytoma originating from the thymus. Gen Thorac Cardiovasc Surg 56:606–609CrossRefPubMedPubMedCentralGoogle Scholar
  144. 144.
    Inoue M, Marx A, Zettl A, Ströbel P, Müller-Hermelink HK, Starostik P (2002) Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 161:1507–1513PubMedPubMedCentralCrossRefGoogle Scholar
  145. 145.
    Inoue M, Nose N, Nishikawa H, Takahashi M, Zen Y, Kawaguchi M (2007) Successful treatment of sclerosing mediastinitis with a high serum IgG4 level. Gen Thorac Cardiovasc Surg 55:431–433CrossRefPubMedPubMedCentralGoogle Scholar
  146. 146.
    Inoue M, Starostik P, Zettl A, Ströbel P, Schwarz S, Scaravilli F, Henry K, Willcox N, Müller-Hermelink HK, Marx A (2003) Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 63:3708–3715PubMedPubMedCentralGoogle Scholar
  147. 147.
    Inoue Y, True LD, Martins RG (2009) Thymic carcinoma associated with paraneoplastic polymyositis. J Clin Oncol 27:e33–34CrossRefPubMedPubMedCentralGoogle Scholar
  148. 148.
    Iyoda A, Hiroshima K, Yusa T, Toyozaki T, Fujisawa T, Ohwada H (2000) The primary mediastinal growing teratoma syndrome. Anticancer Res 20:3723–3726PubMedPubMedCentralGoogle Scholar
  149. 149.
    Jain RK, Mehta RJ, Henley JD, Kesler KA, Loehrer PJ, Badve S (2010) WHO types A and AB thymomas: not always benign. Mod Pathol 23:1641–1649CrossRefPubMedPubMedCentralGoogle Scholar
  150. 150.
    Janda A, Sedlacek P, Honig M, Friedrich W, Champagne M, Matsumoto T, Fischer A, Neven B, Contet A, Bensoussan D, Bordigoni P, Loeb D, Savage W, Jabado N, Bonilla FA, Slatter MA, Davies EG, Gennery AR (2010) Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly. Blood 116:2229–2236PubMedPubMedCentralCrossRefGoogle Scholar
  151. 151.
    Jansson JO, Svensson J, Bengtsson BA, Frohman LA, Ahlman H, Wangberg B, Nilsson O, Nilsson M (1998) Acromegaly and Cushing’s syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6. Clin Endocrinol (Oxf) 48: 243–250CrossRefPubMedPubMedCentralGoogle Scholar
  152. 152.
    Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC (1995) The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151–155CrossRefPubMedPubMedCentralGoogle Scholar
  153. 153.
    Joshi VV, Oleske JM, Connor EM (1990) Morphologic findings in children with acquired immune deficiency syndrome: pathogenesis and clinical implications. Pediatr Pathol 10(1-2):155–165.CrossRefPubMedPubMedCentralGoogle Scholar
  154. 154.
    Judd RL (1987) Massive thymic hyperplasia with myoid cell differentiation. Hum Pathol 18:1180–1183CrossRefPubMedPubMedCentralGoogle Scholar
  155. 155.
    Kalhor N, Suster S, Moran CA (2010) Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases. Am J Clin Pathol 133:618–622CrossRefPubMedPubMedCentralGoogle Scholar
  156. 156.
    Kalman L, Lindegren ML, Kobrynski L, Vogt R, Hannon H, Howard JT, Buckley R (2004) Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review. Genet Med 6:16–26CrossRefPubMedPubMedCentralGoogle Scholar
  157. 157.
    Katakura H, Fukuse T, Shiraishi I, Hayatsu E, Nishijo K, Toguchida J, Nakashima Y, Wada H (2009) Mediastinal synovial sarcoma. Thorac Cardiovasc Surg 57:183–185CrossRefPubMedPubMedCentralGoogle Scholar
  158. 158.
    Kelesidis T, Yang O (2010) Good’s syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clin Immunol 135:347–363CrossRefPubMedPubMedCentralGoogle Scholar
  159. 159.
    Kelleher CM, Forcione DG, Gee MS, Mino-Kenudson M (2012) Case records of the Massachusetts General Hospital. Case 10-2012. A 16-year-old boy with epigastric pain and a mediastinal mass. N Engl J Med 366:1241–1249CrossRefPubMedPubMedCentralGoogle Scholar
  160. 160.
    Kesler KA, Brooks JA, Rieger KM, Fineberg NS, Einhorn LH, Brown JW (2003) Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery. J Thorac Cardiovasc Surg 125:913–923CrossRefPubMedPubMedCentralGoogle Scholar
  161. 161.
    Kesler KA, Rieger KM, Ganjoo KN, Sharma M, Fineberg NS, Einhorn LH, Brown JW (1999) Primary mediastinal nonseminomatous germ cell tumors: the influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 118:692–700CrossRefPubMedPubMedCentralGoogle Scholar
  162. 162.
    Khowaja A, Johnson-Rabbett B, Bantle J, Moheet A (2014) Hypoglycemia mediated by paraneoplastic production of Insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review. BMC Endocr Disord 14:49Google Scholar
  163. 163.
    Kiffer JD, Sandeman TF (1999) Primary malignant mediastinal germ cell tumours: a literature review and a study of 18 cases. Australas Radiol 43:58–68CrossRefPubMedPubMedCentralGoogle Scholar
  164. 164.
    Kilis-Pstrusinska K, Medynska A, Zwolinska D, Dobaczewski G (2008) Lymphoepithelioma-like thymic carcinoma in a 16-year-old boy with nephrotic syndrome – a case report. Pediatr Nephrol 23:1001–1003CrossRefPubMedPubMedCentralGoogle Scholar
  165. 165.
    Kirchner T, Schalke B, Melms A, von Kugelgen T, Müller-Hermelink HK (1986) Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis. Virchows Arch B Cell Pathol Incl Mol Pathol 52:237–257CrossRefPubMedPubMedCentralGoogle Scholar
  166. 166.
    Kisand K, Wolff BAS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A (2010) Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 207:299–308PubMedPubMedCentralCrossRefGoogle Scholar
  167. 167.
    Kisand K, Lilic D, Casanova JL, Peterson P, Meager A, Willcox N (2011) Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications. Eur J Immunol 41:1517–1527CrossRefPubMedPubMedCentralGoogle Scholar
  168. 168.
    Kissin CM, Husband JE, Nicholas D, Eversman W (1987) Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology 163:67–70CrossRefPubMedPubMedCentralGoogle Scholar
  169. 169.
    Klein L, Kyewski B, Allen PM, Hogquist KA (2014) Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol 14:377–391PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Kline ME, Patel BU, Agosti SJ (1990) Noninfiltrating angiolipoma of the mediastinum. Radiology 175:737–738CrossRefPubMedPubMedCentralGoogle Scholar
  171. 171.
    Knapp RH, Hurt RD, Payne WS, Farrow GM, Lewis BD, Hahn RG, Muhm JR, Earle JD (1985) Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg 89:82–89PubMedPubMedCentralGoogle Scholar
  172. 172.
    Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443–1452CrossRefPubMedPubMedCentralGoogle Scholar
  173. 173.
    Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y (1994) A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 44:359–367CrossRefPubMedPubMedCentralGoogle Scholar
  174. 174.
    Kollmannsberger C, Beyer J, Droz JP, Harstrick A, Hartmann JT, Biron P, Flechon A, Schoffski P, Kuczyk M, Schmoll HJ, Kanz L, Bokemeyer C (1998) Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol 16:3386–3391CrossRefPubMedPubMedCentralGoogle Scholar
  175. 175.
    Kondo K, Monden Y (2003) Lymphogenous and hematogenous metastasis of thymic epithelial tumors. Ann Thorac Surg 76:1859–1864 (discussion 1864–1855)CrossRefPubMedPubMedCentralGoogle Scholar
  176. 176.
    Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Lucchi M, Marino M, Marom EM, Nicholson AG, Ruffini E (2014) Staging, Prognostic Factors C. Members of the Advisory B, Participating Institutions of the Thymic D (The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9 (Suppl 2): S81–87)Google Scholar
  177. 177.
    Koppula BR, Pipavath S, Lewis DH (2009) Epstein-Barr virus (EBV) associated lymphoepithelioma-like thymic carcinoma associated with paraneoplastic syndrome of polymyositis: a rare tumor with rare association. Clin Nucl Med 34:686–688PubMedPubMedCentralCrossRefGoogle Scholar
  178. 178.
    Korst RJ, Kansler AL, Christos PJ, Mandal S (2009) Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 87:1641–1647PubMedPubMedCentralCrossRefGoogle Scholar
  179. 179.
    Kulke MH, Lenz HJ, Meropol NJ, Posey J, Ryan DP, Picus J, Bergsland E, Stuart K, Tye L, Huang X, Li JZ, Baum CM, Fuchs CS (2008) Activity of sunitinib in patients with advanced neuroendocrine tumors. J Clin Oncol 26:3403–3410PubMedPubMedCentralCrossRefGoogle Scholar
  180. 180.
    Kuo T, Shih LY (2001) Histologic types of thymoma associated with pure red cell aplasia: a study of five cases including a composite tumor of organoid thymoma associated with an unusual lipofibroadenoma. Int J Surg Pathol 9:29–35PubMedPubMedCentralCrossRefGoogle Scholar
  181. 181.
    Kurzrock EA, Tunuguntla HS, Busby JE, Gandour-Edwards R, Goldman LA (2002) Klinefelter’s syndrome and precocious puberty: a harbinger for tumor. Urology 60:514PubMedPubMedCentralCrossRefGoogle Scholar
  182. 182.
    Ladanyi M, Roy I (1988) Mediastinal germ cell tumors and histiocytosis. Hum Pathol 19:586–590PubMedPubMedCentralCrossRefGoogle Scholar
  183. 183.
    Ladanyi M, Samaniego F, Reuter VE, Motzer RJ, Jhanwar SC, Bosl GJ, Chaganti RS (1990) Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors. J Natl Cancer Inst 82:221–227PubMedPubMedCentralCrossRefGoogle Scholar
  184. 184.
    Lamy AL, Fradet GJ, Luoma A, Nelems B (1994) Anterior and middle mediastinum paraganglioma: complete resection is the treatment of choice. Ann Thorac Surg 57:249–252PubMedPubMedCentralCrossRefGoogle Scholar
  185. 185.
    Lancaster KJ, Liang CY, Myers JC, McCabe KM (1997) Goblet cell carcinoid arising in a mature teratoma of the mediastinum. Am J Surg Pathol 21:109–113PubMedPubMedCentralCrossRefGoogle Scholar
  186. 186.
    Lang-Lazdunski L, Pons F, Jancovici R (2003) Malignant „Triton“ tumor of the posterior mediastinum: prolonged survival after staged resection. Ann Thorac Surg 75:1645–1648PubMedPubMedCentralCrossRefGoogle Scholar
  187. 187.
    Latza U, Foss HD, Durkop H, Eitelbach F, Dieckmann KP, Loy V, Unger M, Pizzolo G, Stein H (1995) CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am J Pathol 146:463–471PubMedPubMedCentralGoogle Scholar
  188. 188.
    Lauriola L, Erlandson RA, Rosai J (1998) Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol 22:1059–1066CrossRefPubMedPubMedCentralGoogle Scholar
  189. 189.
    Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A (2005) Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64:536–538CrossRefPubMedPubMedCentralGoogle Scholar
  190. 190.
    Le Pimpec-Barthes F, Cazes A, Bagan P, Badia A, Vlas C, Hernigou A, Pricopi C, Riquet M (2010) Mediastinal cysts: clinical approach and treatment. Rev Pneumol Clin 66:52–62CrossRefPubMedPubMedCentralGoogle Scholar
  191. 191.
    Lee GY, Yang WI, Jeung HC, Kim SC, Seo MY, Park CH, Chung HC, Rha SY (2007) Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization. BMC Genomics 8:305PubMedPubMedCentralCrossRefGoogle Scholar
  192. 192.
    Lefvert AK, Zhao Y, Ramanujam R, Yu S, Pirskanen R, Hammarstrom L (2008) PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis. J Neuroimmunol 197:110–113CrossRefPubMedPubMedCentralGoogle Scholar
  193. 193.
    Leite MI, Jones M, Ströbel P, Marx A, Gold R, Niks E, Verschuuren JJ, Berrih-Aknin S, Scaravilli F, Canelhas A, Morgan BP, Vincent A, Willcox N (2007) Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. Am J Pathol 171:893–905PubMedPubMedCentralCrossRefGoogle Scholar
  194. 194.
    Leite MI, Ströbel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57:444–448CrossRefPubMedPubMedCentralGoogle Scholar
  195. 195.
    Lemarie E, Assouline PS, Diot P, Regnard JF, Levasseur P, Droz JP, Ruffie P (1992) Primary mediastinal germ cell tumors. Results of a French retrospective study. Chest 102:1477–1483CrossRefPubMedPubMedCentralGoogle Scholar
  196. 196.
    Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9:495–515CrossRefPubMedPubMedCentralGoogle Scholar
  197. 197.
    Liu TZ, Zhang DS, Liang Y, Zhou NN, Gao HF, Liu KJ, Wu HY (2011) Treatment strategies and prognostic factors of patients with primary germ cell tumors in the mediastinum. J Cancer Res Clin Oncol 137:1607–1612PubMedPubMedCentralCrossRefGoogle Scholar
  198. 198.
    Longo F, De Filippis L, Zivi A, Vitolo D, Del Signore E, Gori B, Diso D, Anile M, Venuta F, De Giacomo T, Coloni CF (2012) Efficacy and tolerability of long-acting octreotide in the treatment of thymic tumors: results of a pilot trial. Am J Clin Oncol 35:105–109PubMedPubMedCentralCrossRefGoogle Scholar
  199. 199.
    Macchiarini P, Ostertag H (2004) Uncommon primary mediastinal tumours. Lancet Oncol 5:107–118PubMedPubMedCentralCrossRefGoogle Scholar
  200. 200.
    Maeda D, Ota S, Ikeda S, Kawano R, Hata E, Nakajima J, Mori M, Fukayama M (2009) Mucinous adenocarcinoma of the thymus: a distinct variant of thymic carcinoma. Lung Cancer 64:22–27PubMedPubMedCentralCrossRefGoogle Scholar
  201. 201.
    Maggadottir SM, Sullivan KE (2013) The diverse clinical features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J Allergy Clin Immunol Pract 1:589–594PubMedPubMedCentralCrossRefGoogle Scholar
  202. 202.
    Makimoto Y, Nabeshima K, Iwasaki H, Ishiguro A, Miyoshi T, Shiraishi T, Iwasaki A, Shirakusa T (2005) Inflammatory myofibroblastic tumor of the posterior mediastinum: an older adult case with anaplastic lymphoma kinase abnormalities determined using immunohistochemistry and fluorescence in situ hybridization. Virchows Arch 446:451–455PubMedPubMedCentralCrossRefGoogle Scholar
  203. 203.
    Maniaol AH, Elsais A, Lorentzen AR, Owe JF, Viken MK, Saether H, Flam ST, Brathen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012) Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population. PLoS ONE 7:e36603PubMedPubMedCentralCrossRefGoogle Scholar
  204. 204.
    Manivel C, Wick MR, Abenoza P, Rosai J (1986) The occurrence of sarcomatous components in primary mediastinal germ cell tumors. Am J Surg Pathol 10:711–717PubMedPubMedCentralCrossRefGoogle Scholar
  205. 205.
    Marchevsky AM (1999) Mediastinal tumors of peripheral nervous system origin. Semin Diagn Pathol 16:65–78PubMedPubMedCentralGoogle Scholar
  206. 206.
    Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A, Weetman R, Cullen J, Rogers P, Vinocur C, Stolar C, Rescorla F, Hawkins E, Heifetz S, Rao PV, Krailo M, Castleberry RP (1999) Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children’s Cancer Group Intergroup Study. J Clin Oncol 17:2137–2143PubMedPubMedCentralCrossRefGoogle Scholar
  207. 207.
    Marx A, Porubsky S, Belharazem D, Saruhan-Direskeneli G, Schalke B, Ströbel P, Weis CA (2015) Thymoma related myasthenia gravis in humans and potential animal models. Exp Neurol 270:55–65PubMedPubMedCentralCrossRefGoogle Scholar
  208. 208.
    Marx A, Rieker R, Toker A, Langer F, Ströbel P (2011) Thymic carcinoma: is it a separate entity? From molecular to clinical evidence. Thorac Surg Clin 21: 25–31 v–viPubMedPubMedCentralCrossRefGoogle Scholar
  209. 209.
    Marx A, Willcox N, Leite MI, Chuang WY, Schalke B, Nix W, Ströbel P (2010) Thymoma and paraneoplastic myasthenia gravis. Autoimmunity 43:413–427PubMedPubMedCentralCrossRefGoogle Scholar
  210. 210.
    Meager A, Visvalingam K, Peterson P, Moll K, Murumagi A, Krohn K, Eskelin P, Perheentupa J, Husebye E, Kadota Y, Willcox N (2006) Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. Plos Med 3:e289PubMedPubMedCentralCrossRefGoogle Scholar
  211. 211.
    Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M (2012) Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients. J Clin Endocrinol Metab 97:1114–1124CrossRefPubMedPubMedCentralGoogle Scholar
  212. 212.
    Mesnard-Rouiller L, Bismuth J, Wakkach A, Poea-Guyon S, Berrih-Aknin S (2004) Thymic myoid cells express high levels of muscle genes. J Neuroimmunol 148:97–105CrossRefPubMedPubMedCentralGoogle Scholar
  213. 213.
    Moran CA, Koss MN (1993) Rhabdomyomatous thymoma. Am J Surg Pathol 17:633–636CrossRefPubMedPubMedCentralGoogle Scholar
  214. 214.
    Moran CA, Suster S (2004) „Ancient“ (sclerosing) thymomas: a clinicopathologic study of 10 cases. Am J Clin Pathol 121:867–871CrossRefPubMedPubMedCentralGoogle Scholar
  215. 215.
    Moran CA, Suster S (2000) Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 114:100–110CrossRefPubMedPubMedCentralGoogle Scholar
  216. 216.
    Moran CA, Suster S (1998) Germ-cell tumors of the mediastinum. Adv Anat Pathol 5:1–15CrossRefPubMedPubMedCentralGoogle Scholar
  217. 217.
    Moran CA, Suster S (1997) Primary germ cell tumors of the mediastinum: I. Analysis of 322 cases with special emphasis on teratomatous lesions and a proposal for histopathologic classification and clinical staging. Cancer 80:681–690CrossRefPubMedPubMedCentralGoogle Scholar
  218. 218.
    Moran CA, Suster S (1995) Mediastinal hemangiomas: a study of 18 cases with emphasis on the spectrum of morphological features. Hum Pathol 26:416–421CrossRefPubMedPubMedCentralGoogle Scholar
  219. 219.
    Moran CA, Suster S (1997) Primary mediastinal choriocarcinomas: a clinicopathologic and immunohistochemical study of eight cases. Am J Surg Pathol 21:1007–1012CrossRefPubMedPubMedCentralGoogle Scholar
  220. 220.
    Moran CA, Suster S, Fishback N, Koss MN (1993) Mediastinal paragangliomas. A clinicopathologic and immunohistochemical study of 16 cases. Cancer 72:2358–2364CrossRefPubMedPubMedCentralGoogle Scholar
  221. 221.
    Moran CA, Suster S, Przygodzki RM, Koss MN (1997) Primary germ cell tumors of the mediastinum: II. Mediastinal seminomas – a clinicopathologic and immunohistochemical study of 120 cases. Cancer 80:691–698CrossRefPubMedPubMedCentralGoogle Scholar
  222. 222.
    Moreira AL, Won HH, McMillan R, Huang J, Riely GJ, Ladanyi M, Berger MF (2015) Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis. J Thorac Oncol 10:373–380PubMedPubMedCentralCrossRefGoogle Scholar
  223. 223.
    Mori T, Nomori H, Ikeda K, Kobayashi H, Iwatani K, Kobayashi T (2007) The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy. J Thorac Cardiovasc Surg 133:364–368CrossRefPubMedPubMedCentralGoogle Scholar
  224. 224.
    Morinaga S, Nomori H, Kobayashi R, Atsumi Y (1994) Well-differentiated adenocarcinoma arising from mature cystic teratoma of the mediastinum (teratoma with malignant transformation). Report of a surgical case. Am J Clin Pathol 101:531–534CrossRefPubMedPubMedCentralGoogle Scholar
  225. 225.
    Morita S, Goto A, Sakatani T, Ota S, Murakawa T, Nakajima J, Maeda E, Fukayama M (2011) Multicystic mesothelioma of the pericardium. Pathol Int 61:319–321CrossRefPubMedPubMedCentralGoogle Scholar
  226. 226.
    Moser B, Schiefer AI, Janik S, Marx A, Prosch H, Pohl W, Neudert B, Scharrer A, Klepetko W, Mullauer L (2015) Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol 39:541–548CrossRefPubMedPubMedCentralGoogle Scholar
  227. 227.
    Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS, Reuter VE (1998) Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159:133–138PubMedPubMedCentralCrossRefGoogle Scholar
  228. 228.
    Myhre AG, Halonen M, Eskelin P, Ekwall O, Hedstrand H, Rorsman F, Kampe O, Husebye ES (2001) Autoimmune polyendocrine syndrome type 1 (APS I) in Norway. Clin Endocrinol 54:211–217CrossRefGoogle Scholar
  229. 229.
    Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC (2000) Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 46:927–933PubMedPubMedCentralCrossRefGoogle Scholar
  230. 230.
    Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398CrossRefPubMedPubMedCentralGoogle Scholar
  231. 231.
    Nagvekar N, Moody AM, Moss P, Roxanis I, Curnow J, Beeson D, Pantic N, Newsom-Davis J, Vincent A, Willcox N (1998) A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. J Clin Invest 101:2268–2277PubMedPubMedCentralCrossRefGoogle Scholar
  232. 232.
    Nasseri F, Eftekhari F (2010) Clinical and radiologic review of the normal and abnormal thymus: pearls and pitfalls. Radiographics 30:413–428CrossRefPubMedPubMedCentralGoogle Scholar
  233. 233.
    Nayak HK, Vangipuram DR, Sonika U, Kar P, Kumar N, Kapoor N (2011) Mediastinal mass-a rare presentation of desmoplastic small round cell tumour. BMJ Case Rep.  https://doi.org/10.1136/bcr.10.2011.5042CrossRefPubMedPubMedCentralGoogle Scholar
  234. 234.
    Nehls M, Kyewski B, Messerle M, Waldschutz R, Schuddekopf K, Smith AJ, Boehm T (1996) Two genetically separable steps in the differentiation of thymic epithelium. Science 272:886–889CrossRefPubMedPubMedCentralGoogle Scholar
  235. 235.
    Neiman RS, Orazi A (1999) Mediastinal non-seminomatous germ cell tumours: their association with non-germ cell malignancies. Pathol Res Pract 195:589–594CrossRefPubMedPubMedCentralGoogle Scholar
  236. 236.
    Nenninger R, Schultz A, Hoffacker V, Helmreich M, Wilisch A, Vandekerckhove B, Hunig T, Schalke B, Schneider C, Tzartos S, Kalbacher H, Müller-Hermelink HK, Marx A (1998) Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest 78:743–753PubMedPubMedCentralGoogle Scholar
  237. 237.
    Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G (1990) Hematologic neoplasia associated with primary mediastinal germ-cell tumors. N Engl J Med 322:1425–1429CrossRefPubMedPubMedCentralGoogle Scholar
  238. 238.
    Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P, Staging, Prognostic Factors C, Members of the Advisory B, Participating Institutions of the Thymic D (2014) The IASLC/ITMIG Thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(Suppl 2):S73–S80CrossRefPubMedPubMedCentralGoogle Scholar
  239. 239.
    Oaks J, Margolis DJ (2007) Spindle cell lipoma of the mediastinum: a differential consideration for liposarcoma. J Thorac Imaging 22:355–357CrossRefPubMedPubMedCentralGoogle Scholar
  240. 240.
    Ochs HD, Notarangelo LD (2005) Structure and function of the Wiskott-Aldrich syndrome protein. Curr Opin Hematol 12:284–291CrossRefPubMedPubMedCentralGoogle Scholar
  241. 241.
    Ohtsuka M, Satoh H, Inoue M, Yazawa T, Yamashita YT, Sekizawa K, Hasegawa S (2000) Disseminated metastasis of neuroblastomatous component in immature mediastinal teratoma: a case report. Anticancer Res 20:527–530PubMedPubMedCentralGoogle Scholar
  242. 242.
    Okabe H (1966) Thymic lymph follicles; a histopathological study of 1,356 autopsy cases. Acta Pathol Jpn 16:109–130PubMedPubMedCentralGoogle Scholar
  243. 243.
    Okabe N, Inoue T, Watanabe Y, Muto S, Hasegawa T, Ohsugi J, Higuchi M, Shio Y, Suzuki H (2014) Two cases of thymic carcinoid treated with octreotide long-acting repeatable. Gan To Kagaku Ryoho 41:879–883PubMedPubMedCentralGoogle Scholar
  244. 244.
    Okada S, Ohshima K, Mori M (1994) The Cushing syndrome induced by atrial natriuretic peptide-producing thymic carcinoid. Ann Intern Med 121:75–76CrossRefPubMedPubMedCentralGoogle Scholar
  245. 245.
    Okudela K, Nakamura N, Sano J, Ito T, Kitamura H (2001) Thymic carcinosarcoma consisting of squamous cell carcinomatous and embryonal rhabdomyosarcomatous components. Report of a case and review of the literature. Pathol Res Pract 197:205–210CrossRefPubMedPubMedCentralGoogle Scholar
  246. 246.
    Okuma Y, Hosomi Y, Watanabe K, Yamada Y, Horio H, Maeda Y, Okamura T, Hishima T (2014) Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center. BMC Cancer 14:349PubMedPubMedCentralCrossRefGoogle Scholar
  247. 247.
    Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H, Masaoka A (2002) The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 94:624–632CrossRefPubMedPubMedCentralGoogle Scholar
  248. 248.
    Oliveira AM, Tazelaar HD, Myers JL, Erickson LA, Lloyd RV (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25:815–819CrossRefPubMedPubMedCentralGoogle Scholar
  249. 249.
    Omasa M, Date H, Sozu T, Sato T, Nagai K, Yokoi K, Okamoto T, Ikeda N, Tanaka F, Maniwa Y, Japanese Association for Research on the T (2015) Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study. Cancer 121:1008–1016CrossRefPubMedPubMedCentralGoogle Scholar
  250. 250.
    Oosterhuis JW, Looijenga LH (2005) Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210–222CrossRefPubMedPubMedCentralGoogle Scholar
  251. 251.
    Ortman CL, Dittmar KA, Witte PL, Le PT (2002) Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol 14:813–822CrossRefPubMedPubMedCentralGoogle Scholar
  252. 252.
    Oshikiri T, Morikawa T, Jinushi E, Kawakami Y, Katoh H (2001) Five cases of the lymphangioma of the mediastinum in adult. Ann Thorac Cardiovasc Surg 7:103–105PubMedPubMedCentralGoogle Scholar
  253. 253.
    Owens C, Irwin M (2012) Neuroblastoma: the impact of biology and cooperation leading to personalized treatments. Crit Rev Clin Lab Sci 49:85–115CrossRefPubMedPubMedCentralGoogle Scholar
  254. 254.
    Palmer RD, Barbosa-Morais NL, Gooding EL, Muralidhar B, Thornton CM, Pett MR, Roberts I, Schneider DT, Thorne N, Tavare S, Nicholson JC, Coleman N, Children’s C, Leukaemia G (2008) Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Res 68:4239–4247CrossRefPubMedPubMedCentralGoogle Scholar
  255. 255.
    Palmieri G, Montella L, Martignetti A, Muto P, Di Vizio D, De Chiara A, Lastoria S (2002) Somatostatin analogs and prednisone in advanced refractory thymic tumors. Cancer 94:1414–1420CrossRefPubMedPubMedCentralGoogle Scholar
  256. 256.
    Pan CC, Chen PC, Chiang H (2004) KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas. J Pathol 202:375–381CrossRefPubMedPubMedCentralGoogle Scholar
  257. 257.
    Pan CC, Chen WY, Chiang H (2001) Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases. Am J Surg Pathol 25:111–120CrossRefPubMedPubMedCentralGoogle Scholar
  258. 258.
    Pan CC, Jong YJ, Chen YJ (2005) Comparative genomic hybridization analysis of thymic neuroendocrine tumors. Mod Pathol 18:358–364CrossRefPubMedPubMedCentralGoogle Scholar
  259. 259.
    Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML (2012) Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry. Fam Cancer 11:441–447PubMedPubMedCentralCrossRefGoogle Scholar
  260. 260.
    Papagiannopoulos K, Sheppard MN, Goldstraw P (2000) Thymic hemangioma presenting with recurrent pleural effusion. Ann Thorac Surg 70:297–299CrossRefPubMedPubMedCentralGoogle Scholar
  261. 261.
    Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O’Donnell E (2004) Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol 136:104–110PubMedPubMedCentralCrossRefGoogle Scholar
  262. 262.
    Park MS, Chung KY, Kim KD, Yang WI, Chung JH, Kim YS, Chang J, Kim JH, Kim SK, Kim SK (2004) Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification. Ann Thorac Surg 78:992–997 (discussion 997–998)CrossRefPubMedPubMedCentralGoogle Scholar
  263. 263.
    Passerini L, Sio FR, Porteus MH, Bacchetta R (2014) Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome. Curr Gene Ther 14:422–428PubMedPubMedCentralCrossRefGoogle Scholar
  264. 264.
    Patel DD, Whichard LP, Radcliff G, Denning SM, Haynes BF (1995) Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 15:80–92CrossRefPubMedPubMedCentralGoogle Scholar
  265. 265.
    Peikert T, Colby TV, Midthun DE, Pairolero PC, Edell ES, Schroeder DR, Specks U (2011) Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) 90:412–423CrossRefGoogle Scholar
  266. 266.
    Pellegrino M, Gianotti L, Cassibba S, Brizio R, Terzi A, Borretta G (2012) Neuroblastoma in the elderly and SIADH: case report and review of the literature. Case Rep Med 2012:952645PubMedPubMedCentralCrossRefGoogle Scholar
  267. 267.
    Penzel R, Hoegel J, Schmitz W, Blaeker H, Morresi-Hauf A, Aulmann S, Hecker E, Mechtersheimer G, Otto HF, Rieker RJ (2003) Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka. Int J Cancer 105:494–498CrossRefPubMedPubMedCentralGoogle Scholar
  268. 268.
    Perera J, Huang H (2015) The development and function of thymic B cells. Cell Mol Life Sci 72:2657–2663PubMedPubMedCentralCrossRefGoogle Scholar
  269. 269.
    Perry JS, Lio CW, Kau AL, Nutsch K, Yang Z, Gordon JI, Murphy KM, Hsieh CS (2014) Distinct contributions of aire and antigen-presenting-cell subsets to the generation of self-tolerance in the thymus. Immunity 41:414–426PubMedPubMedCentralCrossRefGoogle Scholar
  270. 270.
    Peterson RD, Kelly WD, Good RA (1964) Ataxia-telangiectasia. Its association with a defective thymus, immunological-deficiency disease, and malignancy. Lancet 1:1189–1193PubMedPubMedCentralCrossRefGoogle Scholar
  271. 271.
    Petkar M, Vaideeswar P, Deshpande JR (2001) Surgical pathology of cystic lesions of the mediastinum. J Postgrad Med 47:235–239PubMedPubMedCentralGoogle Scholar
  272. 272.
    Petrini I, Meltzer PS, Kim IK, Lucchi M, Park KS, Fontanini G, Gao J, Zucali PA, Calabrese F, Favaretto A, Rea F, Rodriguez-Canales J, Walker RL, Pineda M, Zhu YJ, Lau C, Killian KJ, Bilke S, Voeller D, Dakshanamurthy S, Wang Y, Giaccone G (2014) A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet 46:844–849PubMedPubMedCentralCrossRefGoogle Scholar
  273. 273.
    Petrini I, Meltzer PS, Zucali PA, Luo J, Lee C, Santoro A, Lee HS, Killian KJ, Wang Y, Tsokos M, Roncalli M, Steinberg SM, Wang Y, Giaccone G (2012) Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors. Cell Death Dis 3:e351PubMedPubMedCentralCrossRefGoogle Scholar
  274. 274.
    Petrini I, Rajan A, Pham T, Voeller D, Davis S, Gao J, Wang Y, Giaccone G (2013) Whole genome and transcriptome sequencing of a B3 thymoma. PLoS ONE 8:e60572PubMedPubMedCentralCrossRefGoogle Scholar
  275. 275.
    Petrini I, Wang Y, Zucali PA, Lee HS, Pham T, Voeller D, Meltzer PS, Giaccone G (2013) Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors. Clin Cancer Res 19:1960–1971PubMedPubMedCentralCrossRefGoogle Scholar
  276. 276.
    Petrini I, Zucali PA, Lee HS, Pineda MA, Meltzer PS, Walter-Rodriguez B, Roncalli M, Santoro A, Wang Y, Giaccone G (2010) Expression and mutational status of c-kit in thymic epithelial tumors. J Thorac Oncol 5:1447–1453CrossRefPubMedPubMedCentralGoogle Scholar
  277. 277.
    Pevzner A, Schoser B, Peters K, Cosma NC, Karakatsani A, Schalke B, Melms A, Kroger S (2012) Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. J Neurol 259:427–435CrossRefPubMedPubMedCentralGoogle Scholar
  278. 278.
    Plaza JA, Wakely PE Jr., Moran C, Fletcher CD, Suster S (2006) Sclerosing paraganglioma: report of 19 cases of an unusual variant of neuroendocrine tumor that may be mistaken for an aggressive malignant neoplasm. Am J Surg Pathol 30:7–12CrossRefPubMedPubMedCentralGoogle Scholar
  279. 279.
    Poea-Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, Bidault J, Tzartos S, Berrih-Aknin S (2005) Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol 174:5941–5949CrossRefPubMedPubMedCentralGoogle Scholar
  280. 280.
    Poliani PL, Facchetti F, Ravanini M, Gennery AR, Villa A, Roifman CM, Notarangelo LD (2009) Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood 114:105–108PubMedPubMedCentralCrossRefGoogle Scholar
  281. 281.
    Poliani PL, Vermi W, Facchetti F (2009) Thymus microenvironment in human primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol 9:489–495CrossRefPubMedPubMedCentralGoogle Scholar
  282. 282.
    Ratto GB, Costa R, Alloisio A, Maineri P, Ceppa P, Chiaramondia M (2004) Mediastinal chondrosarcoma. Tumori 90:151–153CrossRefPubMedPubMedCentralGoogle Scholar
  283. 283.
    Reeder LB (2000) Neurogenic tumors of the mediastinum. Semin Thorac Cardiovasc Surg 12:261–267CrossRefPubMedPubMedCentralGoogle Scholar
  284. 284.
    Ren W, Xu X, Yan J, Qian X, Liu B (2014) Malignant triton tumor of the anterior mediastinum: a case report. Oncol Lett 7:807–810PubMedPubMedCentralCrossRefGoogle Scholar
  285. 285.
    Rieker RJ, Aulmann S, Penzel R, Schnabel PA, Blaeker H, Esposito I, Morresi-Hauf A, Otto HF, Hecker E, Dienemann H, Schirmacher P, Mechtersheimer G (2005) Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Lett 223:169–174CrossRefPubMedPubMedCentralGoogle Scholar
  286. 286.
    Ripen AM, Nitta T, Murata S, Tanaka K, Takahama Y (2011) Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit beta5t. Eur J Immunol 41:1278–1287CrossRefPubMedPubMedCentralGoogle Scholar
  287. 287.
    Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, Chen CL, Zhang L, Wang R, Su F, Iyer MK, Roychowdhury S, Siddiqui J, Pienta KJ, Kunju LP, Talpaz M, Mosquera JM, Singer S, Schuetze SM, Antonescu CR, Chinnaiyan AM (2013) Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet 45:180–185PubMedPubMedCentralCrossRefGoogle Scholar
  288. 288.
    Rod J, Orbach D, Verite C, Coze C, Stephan JL, Varlet F, Thomas-de-Montpreville V, Reguerre Y, Besse B, Sarnacki S (2014) Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature. Pediatr Blood Cancer 61:1910–1915CrossRefPubMedPubMedCentralGoogle Scholar
  289. 289.
    Roden AC, Erickson-Johnson MR, Yi ES, Garcia JJ (2013) Analysis of MAML2 rearrangement in mucoepidermoid carcinoma of the thymus. Hum Pathol 44:2799–2805CrossRefPubMedPubMedCentralGoogle Scholar
  290. 290.
    Roden AC, Yi ES, Jenkins SM, Donovan JL, Cassivi SD, Garces YI, Marks RS, Aubry MC (2015) Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas. Hum Pathol 46:17–25CrossRefPubMedPubMedCentralGoogle Scholar
  291. 291.
    Rodney AJ, Tannir NM, Siefker-Radtke AO, Liu P, Walsh GL, Millikan RE, Swisher SG, Tu SM, Pagliaro LC (2012) Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience. Urol Oncol 30:879–885CrossRefPubMedPubMedCentralGoogle Scholar
  292. 292.
    Roeyen G, Van Schil P, Somville J, Colpaert C, Van Oosterom A (1999) Chordoma of the mediastinum. Eur J Surg Oncol 25:224–225PubMedPubMedCentralGoogle Scholar
  293. 293.
    Romi F, Aarli JA, Gilhus NE (2007) Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. Eur J Neurol 14:617–620CrossRefPubMedPubMedCentralGoogle Scholar
  294. 294.
    Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA (2003) Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10:701–706CrossRefPubMedPubMedCentralGoogle Scholar
  295. 295.
    Rosado-de-Christenson ML, Pugatch RD, Moran CA, Galobardes J (1994) Thymolipoma: analysis of 27 cases. Radiology 193:121–126CrossRefPubMedPubMedCentralGoogle Scholar
  296. 296.
    Rosado-de-Christenson ML, Templeton PA, Moran CA (1992) From the archives of the AFIP. Mediastinal germ cell tumors: radiologic and pathologic correlation. Radiographics 12:1013–1030CrossRefPubMedPubMedCentralGoogle Scholar
  297. 297.
    Rotstein DL, Bril V (2012) A family with myasthenia gravis with and without thymoma. Can J Neurol Sci 39:539–540CrossRefPubMedPubMedCentralGoogle Scholar
  298. 298.
    Roxanis I, Micklem K, McConville J, Newsom-Davis J, Willcox N (2002) Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis. J Neuroimmunol 125:185–197PubMedPubMedCentralCrossRefGoogle Scholar
  299. 299.
    Roxanis I, Micklem K, Willcox N (2001) True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis. J Neuroimmunol 112:163–173PubMedPubMedCentralCrossRefGoogle Scholar
  300. 300.
    Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, Brunelli A, Evangelista A, Venuta F, European Association of Thoracic Surgeons Thymic Working G (2014) Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database. Eur J Cardiothorac Surg 46:361–368PubMedPubMedCentralCrossRefGoogle Scholar
  301. 301.
    Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, Brunelli A, Guerrera F, Keshavjee S, Altorki N, Schutzner J, Arame A, Spaggiari L, Lim E, Toker A, Venuta F, European Society of Thoracic Surgeons Thymic Working G (2014) Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. J Thorac Oncol 9:541–548PubMedPubMedCentralCrossRefGoogle Scholar
  302. 302.
    Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A, Network of German Cancer R (2013) Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol 37:370–373PubMedPubMedCentralCrossRefGoogle Scholar
  303. 303.
    Saito T, Kimoto M, Nakai S, Ikoma A, Toyoshima H, Kawakami M, Nokubi M, Ishikawa SE (2011) Ectopic ACTH syndrome associated with large cell neuroendocrine carcinoma of the thymus. Intern Med 50:1471–1475PubMedPubMedCentralCrossRefGoogle Scholar
  304. 304.
    Salah S, Salem A (2014) Primary synovial sarcomas of the mediastinum: a systematic review and pooled analysis of the published literature. ISRN Oncol 2014:412527PubMedPubMedCentralGoogle Scholar
  305. 305.
    Sambandam A, Maillard I, Zediak VP, Xu L, Gerstein RM, Aster JC, Pear WS, Bhandoola A (2005) Notch signaling controls the generation and differentiation of early T lineage progenitors. Nat Immunol 6:663–670PubMedPubMedCentralCrossRefGoogle Scholar
  306. 306.
    Sarkaria IS, Bains MS, Sood S, Sima CS, Reuter VE, Flores RM, Motzer RJ, Bosl GJ, Rusch VW (2011) Resection of primary mediastinal non-seminomatous germ cell tumors: a 28-year experience at memorial sloan-kettering cancer center. J Thorac Oncol 6:1236–1241PubMedPubMedCentralCrossRefGoogle Scholar
  307. 307.
    Sartelet H, Lantuejoul S, Armari-Alla C, Pin I, Delattre O, Brambilla E (1998) Solid alveolar rhabdomyosarcoma of the thorax in a child. Histopathology 32:165–171PubMedPubMedCentralCrossRefGoogle Scholar
  308. 308.
    Savino W, Manganella G, Verley JM, Wolff A, Berrih S, Levasseur P, Binet JP, Dardenne M, Bach JF (1985) Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. J Clin Invest 76:1140–1146PubMedPubMedCentralCrossRefGoogle Scholar
  309. 309.
    Schaefer IM, Zardo P, Freermann S, Marx A, Ströbel P, Fischer S (2013) Neuroendocrine carcinoma in a mediastinal teratoma as a rare variant of somatic-type malignancy. Virchows Arch 463:731–735PubMedPubMedCentralCrossRefGoogle Scholar
  310. 310.
    Schaefer IM, Zardo P, Freermann S, Marx A, Ströbel P, Fischer S (2013) Neuroendocrine carcinoma in a mediastinal teratoma as a rare variant of somatic-type malignancy. Virchows Arch 463:731–735PubMedPubMedCentralCrossRefGoogle Scholar
  311. 311.
    Schirosi L, Nannini N, Nicoli D, Cavazza A, Valli R, Buti S, Garagnani L, Sartori G, Calabrese F, Marchetti A, Buttitta F, Felicioni L, Migaldi M, Rea F, Di Chiara F, Mengoli MC, Rossi G (2012) Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors. Ann Oncol 23:2409–2414PubMedPubMedCentralCrossRefGoogle Scholar
  312. 312.
    Schneider DT, Calaminus G, Reinhard H, Gutjahr P, Kremens B, Harms D, Gobel U (2000) Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96. J Clin Oncol 18:832–839PubMedPubMedCentralCrossRefGoogle Scholar
  313. 313.
    Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Gobel U, Harms D, Lauer S, Olson T, Perlman EJ (2002) Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chromosomes Cancer 34:115–125PubMedPubMedCentralCrossRefGoogle Scholar
  314. 314.
    Shakib S, Desanti GE, Jenkinson WE, Parnell SM, Jenkinson EJ, Anderson G (2009) Checkpoints in the development of thymic cortical epithelial cells. J Immunol 182:130–137PubMedPubMedCentralCrossRefGoogle Scholar
  315. 315.
    Shin MS, Ho KJ (1983) Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin’s disease. An immunologic rebound phenomenon? Cancer 51:30–33PubMedPubMedCentralCrossRefGoogle Scholar
  316. 316.
    Shoji T, Fushimi H, Takeda S, Tanio Y (2011) Thymic large-cell neuroendocrine carcinoma: a disease neglected in the ESMO guideline? Ann Oncol 22:2535PubMedPubMedCentralCrossRefGoogle Scholar
  317. 317.
    Shores EW, Van Ewijk W, Singer A (1991) Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment. Eur J Immunol 21:1657–1661PubMedPubMedCentralCrossRefGoogle Scholar
  318. 318.
    Sickles EA, Belliveau RE, Wiernik PH (1974) Primary mediastinal choriocarcinoma in the male. Cancer 33:1196–1203PubMedPubMedCentralCrossRefGoogle Scholar
  319. 319.
    Sieb JP (2014) Myasthenia gravis: an update for the clinician. Clin Exp Immunol 175:408–418PubMedPubMedCentralCrossRefGoogle Scholar
  320. 320.
    Simmons M, Duckworth LV, Scherer K, Drew P, Rush D (2013) Mullerian cysts of the posterior mediastinum: report of two cases and review of the literature. J Thorac Dis 5:E8–E10PubMedPubMedCentralGoogle Scholar
  321. 321.
    Sims GP, Shiono H, Willcox N, Stott DI (2001) Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol 167:1935–1944PubMedPubMedCentralCrossRefGoogle Scholar
  322. 322.
    Sinke RJ, van Asseldonk M, de Bruijn D, Strijk JA, Merkx G, Weghuis OD, de Jong B, Oosterhuis JW, Geurts van Kessel A (1998) Towards the isolation of a human malignant extragonadal germ cell tumour-associated breakpoint in chromosome 11q13. APMIS 106:73–78 (discussion 78–79)PubMedPubMedCentralCrossRefGoogle Scholar
  323. 323.
    Skeie GO, Apostolski S, Evoli A, Gilhus NE, Illa I, Harms L, Hilton-Jones D, Melms A, Verschuuren J, Horge HW, European Federation of Neurological S (2010) Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 17:893–902PubMedPubMedCentralCrossRefGoogle Scholar
  324. 324.
    Smith SM, Ossa-Gomez LJ (1981) A quantitative histologic comparison of the thymus in 100 healthy and diseased adults. Am J Clin Pathol 76:657–665PubMedPubMedCentralCrossRefGoogle Scholar
  325. 325.
    Soga J, Yakuwa Y, Osaka M (1999) Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 5:285–292PubMedPubMedCentralGoogle Scholar
  326. 326.
    Sole F, Bosch F, Woessner S, Perez-Losada A, Cervantes F, Montserrat E, Florensa L, Rozman C (1994) Refractory anemia with excess of blasts and isochromosome 12p in a patient with primary mediastinal germ-cell tumor. Cancer Genet Cytogenet 77:111–113PubMedPubMedCentralCrossRefGoogle Scholar
  327. 327.
    Sommer N, Harcourt GC, Willcox N, Beeson D, Newsom-Davis J (1991) Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 41:1270–1276PubMedPubMedCentralCrossRefGoogle Scholar
  328. 328.
    Somnier FE, Keiding N, Paulson OB (1991) Epidemiology of myasthenia gravis in Denmark. A longitudinal and comprehensive population survey. Arch Neurol 48:733–739PubMedPubMedCentralCrossRefGoogle Scholar
  329. 329.
    Song Y, Su M, Panchatsharam P, Rood D, Lai L (2015) c-Met signalling is required for efficient postnatal thymic regeneration and repair. Immunology 144:245–253PubMedPubMedCentralCrossRefGoogle Scholar
  330. 330.
    Steinmann GG, Klaus B, Müller-Hermelink HK (1985) The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 22:563–575CrossRefPubMedPubMedCentralGoogle Scholar
  331. 331.
    Stella F, Davoli F (2011) Giant mediastinal mature teratoma with increased exocrine pancreatic activity presenting in a young woman: a case report. J Med Case Rep 5:238PubMedPubMedCentralCrossRefGoogle Scholar
  332. 332.
    Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, Durandy A, Griscelli C, Fischer A (1993) Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 123:564–572CrossRefPubMedPubMedCentralGoogle Scholar
  333. 333.
    Strimlan CV, Khasnabis S (1993) Primary mediastinal myelolipoma. Cleve Clin J Med 60:69–71CrossRefPubMedPubMedCentralGoogle Scholar
  334. 334.
    Ströbel P, Bargou R, Wolff A, Spitzer D, Manegold C, Dimitrakopoulou-Strauss A, Strauss L, Sauer C, Mayer F, Hohenberger P, Marx A (2010) Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience. Br J Cancer 103:196–200PubMedPubMedCentralCrossRefGoogle Scholar
  335. 335.
    Ströbel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Müller-Hermelink HK, Marx A (2004) Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22:1501–1509CrossRefPubMedPubMedCentralGoogle Scholar
  336. 336.
    Ströbel P, Chuang WY, Chuvpilo S, Zettl A, Katzenberger T, Kalbacher H, Rieckmann P, Nix W, Schalke B, Gold R, Müller-Hermelink HK, Peterson P, Marx A (2008) Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ann N Y Acad Sci 1132:143–156CrossRefPubMedPubMedCentralGoogle Scholar
  337. 337.
    Ströbel P, Hartmann E, Rosenwald A, Kalla J, Ott G, Friedel G, Schalke B, Kasahara M, Tomaru U, Marx A (2014) Corticomedullary differentiation and maturational arrest in thymomas. Histopathology 64:557–566CrossRefPubMedPubMedCentralGoogle Scholar
  338. 338.
    Ströbel P, Hartmann M, Jakob A, Mikesch K, Brink I, Dirnhofer S, Marx A (2004) Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. N Engl J Med 350:2625–2626CrossRefPubMedPubMedCentralGoogle Scholar
  339. 339.
    Ströbel P, Helmreich M, Kalbacher H, Müller-Hermelink HK, Marx A (2001) Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas. Dev Immunol 8:279–290PubMedPubMedCentralCrossRefGoogle Scholar
  340. 340.
    Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rudiger T, Bauer A, Hoffacker V, Gold R, Nix W, Schalke B, Elert O, Semik M, Müller-Hermelink HK, Marx A (2002) Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Blood 100:159–166CrossRefPubMedPubMedCentralGoogle Scholar
  341. 341.
    Ströbel P, Marino M, Feuchtenberger M, Rouziere AS, Tony HP, Wulbrand U, Forster R, Zettl A, Harris LN, Kreipe H, Laeng RH, Müller-Hermelink HK, Marx A (2005) Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development. J Pathol 207:72–82CrossRefPubMedPubMedCentralGoogle Scholar
  342. 342.
    Ströbel P, Moritz R, Leite MI, Willcox N, Chuang WY, Gold R, Nix W, Schalke B, Kiefer R, Müller-Hermelink HK, Jaretzki Iii A, Newsom-Davis J, Marx A (2008) The ageing and myasthenic thymus: a morphometric study validating a standard procedure in the histological workup of thymic specimens. J Neuroimmunol 201-202:64–73CrossRefPubMedPubMedCentralGoogle Scholar
  343. 343.
    Ströbel P, Murumagi A, Klein R, Luster M, Lahti M, Krohn K, Schalke B, Nix W, Gold R, Rieckmann P, Toyka K, Burek C, Rosenwald A, Müller-Hermelink HK, Pujoll-Borrell R, Meager A, Willcox N, Peterson P, Marx A (2007) Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1). J Pathol 211:563–571CrossRefPubMedPubMedCentralGoogle Scholar
  344. 344.
    Ströbel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumagi A, Sillanpaa N, Peterson P, Hummel V, Rieckmann P, Burek C, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A (2004) Selective loss of regulatory T cells in thymomas. Ann Neurol 56:901–904CrossRefPubMedPubMedCentralGoogle Scholar
  345. 345.
    Ströbel P, Zettl A, Shilo K, Chuang WY, Nicholson AG, Matsuno Y, Gal A, Laeng RH, Engel P, Capella C, Marino M, Chan JK, Rosenwald A, Travis W, Franks TJ, Ellenberger D, Schaefer IM, Marx A (2014) Tumor genetics and survival of thymic neuroendocrine neoplasms: a multi-institutional clinicopathologic study. Genes Chromosomes Cancer 53:738–749CrossRefPubMedPubMedCentralGoogle Scholar
  346. 346.
    Sullivan KE (2001) DiGeorge syndrome/chromosome 22q11.2 deletion syndrome. Curr Allergy Asthma Rep 1:438–444CrossRefPubMedPubMedCentralGoogle Scholar
  347. 347.
    Sung MT, Maclennan GT, Lopez-Beltran A, Zhang S, Montironi R, Cheng L (2008) Primary mediastinal seminoma: a comprehensive assessment integrated with histology, immunohistochemistry, and fluorescence in situ hybridization for chromosome 12p abnormalities in 23 cases. Am J Surg Pathol 32:146–155CrossRefPubMedPubMedCentralGoogle Scholar
  348. 348.
    Suster S, Barbuto D, Carlson G, Rosai J (1991) Multilocular thymic cysts with pseudoepitheliomatous hyperplasia. Hum Pathol 22:455–460PubMedPubMedCentralCrossRefGoogle Scholar
  349. 349.
    Suster S, Moran CA (2005) Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases. Am J Surg Pathol 29:569–578PubMedPubMedCentralCrossRefGoogle Scholar
  350. 350.
    Suster S, Moran CA, Koss MN (1994) Epithelioid hemangioendothelioma of the anterior mediastinum. Clinicopathologic, immunohistochemical, and ultrastructural analysis of 12 cases. Am J Surg Pathol 18:871–881CrossRefPubMedPubMedCentralGoogle Scholar
  351. 351.
    Suzuki H, Koh E, Hoshino I, Kishi H, Saitoh Y (2010) Mediastinal teratoma complicated with acute mediastinitis. Gen Thorac Cardiovasc Surg 58:105–108CrossRefPubMedPubMedCentralGoogle Scholar
  352. 352.
    Tabarin A, Catargi B, Chanson P, Hieronimus S, Corcuff JB, Laurent F, Harter M, Drouillard J, Roger P (1995) Pseudo-tumours of the thymus after correction of hypercortisolism in patients with ectopic ACTH syndrome: a report of five cases. Clin Endocrinol (oxf) 42:207–213CrossRefGoogle Scholar
  353. 353.
    Tackenberg B, Schlegel K, Happel M, Eienbroker C, Gellert K, Oertel WH, Meager A, Willcox N, Sommer N (2009) Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients. J Neuroimmunol 216:85–91CrossRefPubMedPubMedCentralGoogle Scholar
  354. 354.
    Takahashi F, Tsuta K, Nagaoka T, Miyamoto H, Saito Y, Amano H, Uchida K, Morio Y, Shimizu K, Sasaki S, Tominaga S, Uekusa T, Izumi H, Anami Y, Matsuno Y, Takahashi K, Fukuchi Y (2008) Successful resection of dermatomyositis associated with thymic carcinoma: report of a case. Surg Today 38:245–248CrossRefPubMedPubMedCentralGoogle Scholar
  355. 355.
    Takanami I, Takeuchi K, Naruke M (1999) Low-grade fibromyxoid sarcoma arising in the mediastinum. J Thorac Cardiovasc Surg 118:970–971CrossRefPubMedPubMedCentralGoogle Scholar
  356. 356.
    Takeda S, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M, Masaoka A, Matsuda H (2003) Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol 83:24–30CrossRefPubMedPubMedCentralGoogle Scholar
  357. 357.
    Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H (2003) Primary germ cell tumors in the mediastinum: a 50-year experience at a single Japanese institution. Cancer 97:367–376CrossRefPubMedPubMedCentralGoogle Scholar
  358. 358.
    Tan Z, Ying LY, Zhang ZW, Li JH, Gao Z, Qi JC (2010) True thymic hyperplasia in an infant. J Pediatr Surg 45:1711–1713CrossRefPubMedPubMedCentralGoogle Scholar
  359. 359.
    Tateyama H, Eimoto T, Tada T, Mizuno T, Inagaki H, Hata A, Sasaki M, Masaoka A (1995) p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. Am J Clin Pathol 104:375–381CrossRefPubMedPubMedCentralGoogle Scholar
  360. 360.
    Taylor AM, Metcalfe JA, Thick J, Mak YF (1996) Leukemia and lymphoma in ataxia telangiectasia. Blood 87:423–438PubMedPubMedCentralGoogle Scholar
  361. 361.
    Teh BT, Hayward NK, Walters MK, Shepherd JJ, Wilkinson S, Nordenskjold M, Larsson C (1994) Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1. J Med Genet 31:261–262PubMedPubMedCentralCrossRefGoogle Scholar
  362. 362.
    Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P (1998) Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 228:99–105PubMedPubMedCentralCrossRefGoogle Scholar
  363. 363.
    Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO (2007) TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol 31:240–246CrossRefPubMedPubMedCentralGoogle Scholar
  364. 364.
    Thomas A, Rajan A, Berman A, Tomita Y, Brzezniak C, Lee MJ, Lee S, Ling A, Spittler AJ, Carter CA, Guha U, Wang Y, Szabo E, Meltzer P, Steinberg SM, Trepel JB, Loehrer PJ, Giaccone G (2015) Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial. Lancet Oncol 16:177–186PubMedPubMedCentralCrossRefGoogle Scholar
  365. 365.
    Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P (2003) A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 124:141–146CrossRefPubMedPubMedCentralGoogle Scholar
  366. 366.
    Tirabosco R, Lang-Lazdunski L, Diss TC, Amary MF, Rodriguez-Justo M, Landau D, Lorenzi W, Flanagan AM (2009) Clear cell sarcoma of the mediastinum. Ann Diagn Pathol 13:197–200CrossRefPubMedPubMedCentralGoogle Scholar
  367. 367.
    Tomaru U, Ishizu A, Murata S, Miyatake Y, Suzuki S, Takahashi S, Kazamaki T, Ohara J, Baba T, Iwasaki S, Fugo K, Otsuka N, Tanaka K, Kasahara M (2009) Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex. Blood 113:5186–5191CrossRefPubMedPubMedCentralGoogle Scholar
  368. 368.
    Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, O’Neil K, Stover K, El-Naggar A, Griffin JD, Kirsch IR, Kaye FJ (2003) t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 33:208–213CrossRefPubMedPubMedCentralGoogle Scholar
  369. 369.
    Torii Y, Sasano S, Obara T (2005) A case of desmoid tumor involving the posterior mediastinum. Nihon Kokyuki Gakkai Zasshi 43:613–617PubMedPubMedCentralGoogle Scholar
  370. 370.
    Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL (2014) Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of „melanotic schwannoma“. Am J Surg Pathol 38:94–105CrossRefPubMedPubMedCentralGoogle Scholar
  371. 371.
    Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) WHO classification of tumours of the lung, pleura, thymus and heart. IARC, LyonGoogle Scholar
  372. 372.
    Trupiano JK, Rice TW, Herzog K, Barr FG, Shipley J, Fisher C, Goldblum JR (2002) Mediastinal synovial sarcoma: report of two cases with molecular genetic analysis. Ann Thorac Surg 73:628–630CrossRefPubMedPubMedCentralGoogle Scholar
  373. 373.
    Tsuchida M, Yamato Y, Hashimoto T, Saito M, Hayashi J (2001) Recurrent thymic carcinoid tumor in the pleural cavity. 2 cases of long-term survivors. Jpn J Thorac Cardiovasc Surg 49:666–668CrossRefPubMedPubMedCentralGoogle Scholar
  374. 374.
    Ueda Y, Omasa M, Taki T, Okabe R, Cho H, Shoji T, Huang CL, Yuba Y (2012) Thymic neuroblastoma within a thymic cyst in an adult. Case Rep Oncol 5:459–463PubMedPubMedCentralCrossRefGoogle Scholar
  375. 375.
    Ulbright TM, Clark SA, Einhorn LH (1985) Angiosarcoma associated with germ cell tumors. Hum Pathol 16:268–272CrossRefPubMedPubMedCentralGoogle Scholar
  376. 376.
    Ulbright TM, Loehrer PJ, Roth LM, Einhorn LH, Williams SD, Clark SA (1984) The development of non-germ cell malignancies within germ cell tumors. A clinicopathologic study of 11 cases. Cancer 54:1824–1833CrossRefPubMedPubMedCentralGoogle Scholar
  377. 377.
    Uner R, Balim AI, Oktem K (1963) Mediastinal liposarcoma. Report of a case. Dis Chest 43:103–105CrossRefPubMedPubMedCentralGoogle Scholar
  378. 378.
    Uno A, Sakurai M, Onuma K, Yamane Y, Kurita K, Hayashi I, Ikeda M, Hagiwara N, Tominaga K, Hakozaki H (1988) A case of giant mediastinal leiomyoma with long-term survival. Tohoku J Exp Med 156:1–6CrossRefPubMedPubMedCentralGoogle Scholar
  379. 379.
    van de Rijn M, Lombard CM, Rouse RV (1994) Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung. Am J Surg Pathol 18:814–820CrossRefPubMedPubMedCentralGoogle Scholar
  380. 380.
    van Echten J, de Jong B, Sinke RJ, Weghuis DO, Sleijfer DT, Oosterhuis JW (1995) Definition of a new entity of malignant extragonadal germ cell tumors. Genes Chromosomes Cancer 12:8–15CrossRefPubMedPubMedCentralGoogle Scholar
  381. 381.
    van Ewijk W, Hollander G, Terhorst C, Wang B (2000) Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets. Development 127:1583–1591PubMedPubMedCentralGoogle Scholar
  382. 382.
    van Ewijk W, Wang B, Hollander G, Kawamoto H, Spanopoulou E, Itoi M, Amagai T, Jiang YF, Germeraad WT, Chen WF, Katsura Y (1999) Thymic microenvironments, 3-D versus 2-D? Semin Immunol 11:57–64CrossRefPubMedPubMedCentralGoogle Scholar
  383. 383.
    Vasey PA, Dunlop DJ, Kaye SB (1994) Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy. Ann Oncol 5:649–652CrossRefPubMedPubMedCentralGoogle Scholar
  384. 384.
    Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, Ventura L, Osti MF, Francioni F, Coloni GF (2003) Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76:1866–1872 (discussion 1872)CrossRefPubMedPubMedCentralGoogle Scholar
  385. 385.
    Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2:797–804CrossRefPubMedPubMedCentralGoogle Scholar
  386. 386.
    Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM, Survey UKMG (2003) Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 74:1105–1108PubMedPubMedCentralCrossRefGoogle Scholar
  387. 387.
    Vladislav T, Jain RK, Alvarez R, Mehta RJ, Gokmen-Polar Y, Kesler KA, Henley JD, Loehrer PJ Sr., Badve S (2012) Extrathoracic metastases of thymic origin: a review of 35 cases. Mod Pathol 25:370–377CrossRefPubMedPubMedCentralGoogle Scholar
  388. 388.
    Volkl TM, Langer T, Aigner T, Greess H, Beck JD, Rauch AM, Dorr HG (2006) Klinefelter syndrome and mediastinal germ cell tumors. Am J Med Genet A 140:471–481CrossRefPubMedPubMedCentralGoogle Scholar
  389. 389.
    Wakkach A, Guyon T, Bruand C, Tzartos S, Cohen-Kaminsky S, Berrih-Aknin S (1996) Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J Immunol 157:3752–3760PubMedPubMedCentralGoogle Scholar
  390. 390.
    Wang Y, Thomas A, Lau C, Rajan A, Zhu Y, Killian JK, Petrini I, Pham T, Morrow B, Zhong X, Meltzer PS, Giaccone G (2014) Mutations of epigenetic regulatory genes are common in thymic carcinomas. Sci Rep 4:7336PubMedPubMedCentralCrossRefGoogle Scholar
  391. 391.
    Weis CA, Yao X, Deng Y, Detterbeck FC, Marino M, Nicholson AG, Huang J, Ströbel P, Antonicelli A, Marx A, Contributors to the IRD (2015) The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol 10:367–372PubMedPubMedCentralCrossRefGoogle Scholar
  392. 392.
    Weiss JM, Cufi P, Bismuth J, Eymard B, Fadel E, Berrih-Aknin S, Le Panse R (2013) SDF-1/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients. Immunobiology 218:373–381PubMedPubMedCentralCrossRefGoogle Scholar
  393. 393.
    Weissferdt A, Kalhor N, Liu H, Rodriguez J, Fujimoto J, Tang X, Wistuba II, Moran CA (2014) Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases. Hum Pathol 45:2463–2470CrossRefPubMedPubMedCentralGoogle Scholar
  394. 394.
    Weissferdt A, Kalhor N, Moran CA (2015) Cystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases. Histopathology 68:333–338CrossRefPubMedPubMedCentralGoogle Scholar
  395. 395.
    Weissferdt A, Kalhor N, Moran CA (2015) Cystic well differentiated squamous cell carcinoma of the thymus A clinicopathological and immunohistochemical study of 6 cases. Histopathology 68:333–338CrossRefPubMedPubMedCentralGoogle Scholar
  396. 396.
    Weissferdt A, Kalhor N, Suster S, Moran CA (2010) Primary angiosarcomas of the anterior mediastinum: a clinicopathologic and immunohistochemical study of 9 cases. Hum Pathol 41:1711–1717CrossRefPubMedPubMedCentralGoogle Scholar
  397. 397.
    Weissferdt A, Moran CA (2012) Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 138:103–114CrossRefPubMedPubMedCentralGoogle Scholar
  398. 398.
    Weissferdt A, Moran CA (2012) Micronodular thymic carcinoma with lymphoid hyperplasia: a clinicopathological and immunohistochemical study of five cases. Mod Pathol 25:993–999CrossRefPubMedPubMedCentralGoogle Scholar
  399. 399.
    Weissferdt A, Moran CA (2012) Thymic hyperplasia with lymphoepithelial sialadenitis (LESA)-like features: a clinicopathologic and immunohistochemical study of 4 cases. Am J Clin Pathol 138:816–822CrossRefPubMedPubMedCentralGoogle Scholar
  400. 400.
    Weissferdt A, Suster S, Moran CA (2012) Primary mediastinal „thymic“ seminomas. Adv Anat Pathol 19:75–80PubMedPubMedCentralCrossRefGoogle Scholar
  401. 401.
    Weissferdt A, Tang X, Wistuba II, Moran CA (2013) Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Mod Pathol 26:1554–1560PubMedPubMedCentralCrossRefGoogle Scholar
  402. 402.
    White W, Shiu MH, Rosenblum MK, Erlandson RA, Woodruff JM (1990) Cellular schwannoma. A clinicopathologic study of 57 patients and 58 tumors. Cancer 66:1266–1275PubMedPubMedCentralCrossRefGoogle Scholar
  403. 403.
    Willcox N, Leite MI, Kadota Y, Jones M, Meager A, Subrahmanyam P, Dasgupta B, Morgan BP, Vincent A (2008) Autoimmunizing mechanisms in thymoma and thymus. Ann N Y Acad Sci 1132:163–173PubMedPubMedCentralCrossRefGoogle Scholar
  404. 404.
    Willcox N, Schluep M, Ritter MA, Schuurman HJ, Newsom-Davis J, Christensson B (1987) Myasthenic and nonmyasthenic thymoma. An expansion of a minor cortical epithelial cell subset? Am J Pathol 127:447–460PubMedPubMedCentralGoogle Scholar
  405. 405.
    Willcox N, Schluep M, Sommer N, Campana D, Janossy G, Brown AN, Newsom-Davis J (1989) Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects. Q J Med 73:1071–1087PubMedPubMedCentralGoogle Scholar
  406. 406.
    Wilson RW, Moran CA (1998) Primary ependymoma of the mediastinum: a clinicopathologic study of three cases. Ann Diagn Pathol 2:293–300PubMedPubMedCentralCrossRefGoogle Scholar
  407. 407.
    Witkin GB, Rosai J (1989) Solitary fibrous tumor of the mediastinum. A report of 14 cases. Am J Surg Pathol 13:547–557PubMedPubMedCentralCrossRefGoogle Scholar
  408. 408.
    Wolff AS, Karner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kampe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES (2014) Clinical and Serologic Parallels to APS-I in Patients with Thymomas and Autoantigen Transcripts in Their Tumors. J Immunol 193:3880–3890PubMedPubMedCentralCrossRefGoogle Scholar
  409. 409.
    Wolff JA (1967) Wiskott-Aldrich syndrome: clinical, immunologic, and pathologic observations. J Pediatr 70:221–232PubMedPubMedCentralCrossRefGoogle Scholar
  410. 410.
    Woodruff JM, Godwin TA, Erlandson RA, Susin M, Martini N (1981) Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol 5:733–744PubMedPubMedCentralCrossRefGoogle Scholar
  411. 411.
    Wright CD, Wain JC, Wong DR, Donahue DM, Gaissert HA, Grillo HC, Mathisen DJ (2005) Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 130:1413–1421PubMedPubMedCentralCrossRefGoogle Scholar
  412. 412.
    Yamakawa Y, Masaoka A, Hashimoto T, Niwa H, Mizuno T, Fujii Y, Nakahara K (1991) A tentative tumor-node-metastasis classification of thymoma. Cancer 68:1984–1987PubMedPubMedCentralCrossRefGoogle Scholar
  413. 413.
    Yokoi K, Tanaka N, Furukawa K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Yamada T, Ohaki Y, Tajiri T (2008) Male choriocarcinoma with metastasis to the jejunum: a case report and review of the literature. J Nippon Med Sch 75:116–121PubMedPubMedCentralCrossRefGoogle Scholar
  414. 414.
    Yoshikawa T, Noguchi Y, Matsukawa H, Kondo J, Matsumoto A, Nakatani Y, Kitamura H, Ito T (1994) Thymus carcinoid producing parathyroid hormone (PTH)-related protein: report of a case. Surg Today 24:544–547PubMedPubMedCentralCrossRefGoogle Scholar
  415. 415.
    Yu N, Kim HR, Cha YJ, Park EK, Kim JW (2011) Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea. J Korean Med Sci 26:1099–1102PubMedPubMedCentralCrossRefGoogle Scholar
  416. 416.
    Zambudio AR, Lanzas JT, Calvo MJ, Fernandez PJ, Paricio PP (2002) Non-neoplastic mediastinal cysts. Eur J Cardiothorac Surg 22:712–716PubMedPubMedCentralCrossRefGoogle Scholar
  417. 417.
    Zettl A, Ströbel P, Wagner K, Katzenberger T, Ott G, Rosenwald A, Peters K, Krein A, Semik M, Müller-Hermelink HK, Marx A (2000) Recurrent genetic aberrations in thymoma and thymic carcinoma. Am J Pathol 157:257–266PubMedPubMedCentralCrossRefGoogle Scholar
  418. 418.
    Zhang F, Zhang W, Shi H, Ye G, Shi W, Shu Y, Li G (2014) Primary choriocarcinoma of the posterior mediastinum in a male: A case report and review of the literature. Oncol Lett 8:739–741PubMedPubMedCentralCrossRefGoogle Scholar
  419. 419.
    Zhao GQ, Dowell JE (2012) Hematologic malignancies associated with germ cell tumors. Expert Rev Hematol 5:427–437PubMedPubMedCentralCrossRefGoogle Scholar
  420. 420.
    Zhao Y, Shi J, Fan L, Yang J, Hu D, Zhao H (2015) Evaluation of the proposed International Association for the Study of Lung Cancer (IASLC)/International Thymic Malignancies Interest Group (ITMIG) staging revisions in thymic well-differentiated neuroendocrine carcinoma patients. Eur J Cardiothorac Surg 49:569–573PubMedPubMedCentralCrossRefGoogle Scholar
  421. 421.
    Zhao Y, Zhao H, Hu D, Fan L, Shi J, Fang W (2013) Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. Ann Thorac Surg 96:1019–1024PubMedPubMedCentralCrossRefGoogle Scholar
  422. 422.
    Zisis C, Fragoulis S, Rontogianni D, Stratakos G, Bellenis I (2006) Malignant triton tumour of the anterior mediastinum as incidental finding. Monaldi Arch Chest Dis 65:222–224PubMedPubMedCentralGoogle Scholar
  423. 423.
    Zouvelou V, Zisimopoulou P, Rentzos M, Karandreas N, Evangelakou P, Stamboulis E, Tzartos SJ (2013) Double seronegative myasthenia gravis with anti-LRP 4 antibodies. Neuromuscul Disord 23:568–570PubMedPubMedCentralCrossRefGoogle Scholar
  424. 424.
    Zuckerman NS, Howard WA, Bismuth J, Gibson K, Edelman H, Berrih-Aknin S, Dunn-Walters D, Mehr R (2010) Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC. Eur J Immunol 40:1150–1161PubMedPubMedCentralCrossRefGoogle Scholar
  425. 425.
    Zuklys S, Balciunaite G, Agarwal A, Fasler-Kan E, Palmer E, Hollander GA (2000) Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol 165:1976–1983PubMedPubMedCentralCrossRefGoogle Scholar
  426. 426.
    Radovich M et al (2018) The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell 33(2):244–258PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Institut für PathologieUniversitätsmedizin GöttingenGöttingenDeutschland
  2. 2.Institut für PathologieUniversitätsmedizin Mannheim der Universität HeidelbergMannheimDeutschland

Personalised recommendations